I just read an article by Abbie Rosner in Forbes Magazine about a cannabis entrepreneur making products to treat her own rare condition. There was no mention in the article of making money. Wow, someone doing good by doing good in the marijuana space in mainstream media!

It piqued my interest. Here was a businesswoman who belonged to “a subset of medical cannabis companies established by people who healed themselves with their own plant-based medicine, then went into business to serve others”.

For years people with skills, ability, and financial wherewithal who found themselves in a similar situation of rare disease diagnoses embarked on research and often founded traditional pharmaceutical companies as the path to solve their problem. While disappointing that she suffers, it is nevertheless exciting to see people like Constance Finley doing this critical work with cannabis.

Cannabis ExtractsMs. Finley says “Cannabis is too often considered a commodity. But like grapes for fine wine, cannabis reflects the conditions under which it is grown.”  She continues “In another life, I might have been a scientist,…Instead, I focused on kitchen sciences and creating businesses. And bringing people back to plant-based medicine is my destiny.”  So, while I wholeheartedly commend her, I also offer a challenge to good people like Constance and also others in her production situation.

She’s helping people.She understands product and manufacturing quality are essential and that is perhaps what sets her apart from many others. But it’s not enough. She’s helping people, but could help many more. (A simple definition of ‘rare disease’ indicates a minimum of 200,000 people in the US suffer from a ‘rare disease’.)

Since Constance Therapeutics makes quality stable products, I would recommend they conduct the research and publish the results. If people are being helped, let’s test so we can publish. Publishing will educate healthcare providers and make them aware that  there may be a real workable solution for the patients who suffer like Constance once did – and make them more likely to refer.

Drug research isn’t cheap.  New drug entities must first pass rigorous testing to make sure the compound won’t kill or cause organ damage to potential patients, before being tested to see if the product has any beneficial effects. Cannabis research does have some advantages.   We know that cannabis has few and limited side effects and doesn’t cause any organ damage or failure, reducing research cost dramatically.

I think Constance Therapeutics would like to bring life improving therapy to increasing numbers of people that are similarly suffering yet either aren’t aware of Constance Finley and others’ good work. My hat is off to you Constance, and all the others out there who are pioneering new applications of cannabis products to improve healthcare!

Source: https://www.forbes.com/sites/abbierosner/2019/01/24/constance-finleys-midlife-detour-to-cannabis-extraction-connoisseur/?fbclid=IwAR31hvcDn02VfpxLZkrxq1C3bn1iarN5hX_bnmcLk_iuljujjz66NIbI5kU#3c5059e335c6

About Joseph Sameh

Joseph (Joe) Sameh, President of CannaTrials, is a healthcare entrepreneur and recognized industry leader, author, and speaker.  He has more than a decade experience as medical practice manager with a previous 30 year career in computer, telephone, and communications systems. His unique contributions to better patient access in clinical trials, patient recruitment ,and enhanced management of the process, are widely recognized. Among his inventions, Sameh invented what we know of as the patient communications portal in your electronic health record that allows you to communicate with your physician.  Starting a call center for doctors in Chicago, MediConnect evolved to provide services to more than 17,000 physicians nationwide plus the majority of Chicago area hospitals.


Get your CannaTrials News.